SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback